Back to search
FDAFDA · Food and drugs·Recall number D-0091-2018

Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Columbus, Ohio 43217, NDC 68084-046-01

Published November 29, 2017 · Recall initiated: October 24, 2017

Summary

FDA records drug Class II recall D-0091-2018, published November 29, 2017 and initiated October 24, 2017. Recalling firm: Amerisource Health Services; Status: Terminated; Reported quantity: 74 cartons (cartons of 100 individual unit doses); Lot: Lot 172291. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email if PAROXETINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PAROXETINE
Manufacturer
Amerisource Health Services
Distributor
Nationwide in the USA
Lot
Lot 172291
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Columbus, Ohio 43217, NDC 68084-046-01 recalled?

Yes. FDA published recall D-0091-2018 on November 29, 2017. Reported hazard: Presence of Foreign Tablets/Capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PAROXETINE.